-transparent.png){kind=logo}
The effects of histamine H3-receptor antagonists, thioperamide, and clobenpropit on amygdaloid kindled seizures were investigated in rats. Both intracerebroventricular (i.c.v.) and intraperitoneal (i.p.) injections of H3-antagonists resulted in a dose-related inhibition of amygdaloid kindled seizures. An inhibition induced by thioperamide was antagonized by an H3-agonist [(R)-alpha-methylhistamine] and H1-antagonists (diphenhydramine and chlorpheniramine). On the other hand, an H2-antagonist (cimetidine and ranitidine) caused no antagonistic effect. Metoprine, an inhibitor of N-methyltransferase was also effective in inhibiting amygdaloid kindled seizure, and this effect was augmented by thioperamide treatment.
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
March 2004,
Brain research bulletin,
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
October 2001,
Behavioural brain research,
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
December 2001,
Epilepsia,
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
May 2001,
Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
January 2005,
Neuroscience,
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
May 1984,
Neuroscience letters,
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
May 1987,
Journal of pharmacobio-dynamics,
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
June 2009,
Chinese medical journal,
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
March 1981,
Neuropharmacology,
H Kakinoki, and
K Ishizawa, and
M Fukunaga, and
Y Fujii, and
C Kamei
May 1982,
Pharmacology, biochemistry, and behavior,
